Catalina Capital Group LLC Buys Shares of 15,948 Waldencast plc (NASDAQ:WALD)

Catalina Capital Group LLC bought a new position in Waldencast plc (NASDAQ:WALD) in the 3rd quarter, HoldingsChannel reports. The fund bought 15,948 shares of the company’s stock, valued at approximately $58,000.

A number of other institutional investors and hedge funds have also modified their holdings of WALD. Marshall Wace LLP purchased a new stake in shares of Waldencast in the second quarter worth approximately $37,000. McAdam LLC acquired a new position in shares of Waldencast in the third quarter worth $62,000. Cubist Systematic Strategies LLC purchased a new position in Waldencast in the second quarter valued at about $85,000. Norden Group LLC acquired a new position in Waldencast in the 1st quarter worth about $92,000. Finally, Bleakley Financial Group LLC raised its stake in shares of Waldencast by 75.2% during the 3rd quarter. Bleakley Financial Group LLC now owns 26,297 shares of the company’s stock worth $96,000 after purchasing an additional 11,288 shares in the last quarter. Hedge funds and other institutional investors own 41.97% of the company’s stock.

Waldencast Stock Performance

NASDAQ:WALD opened at $3.61 on Friday. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.78 and a current ratio of 1.47. The firm’s 50-day moving average is $3.64 and its 200-day moving average is $3.78. Waldencast plc has a 52-week low of $2.40 and a 52-week high of $12.00.

Analysts Set New Price Targets

A number of equities analysts recently commented on WALD shares. Telsey Advisory Group restated an “outperform” rating and issued a $6.00 price objective on shares of Waldencast in a report on Wednesday, October 9th. Canaccord Genuity Group started coverage on Waldencast in a research report on Friday, October 25th. They issued a “buy” rating and a $5.00 price target for the company. Canaccord Genuity Group assumed coverage on Waldencast in a report on Friday, October 25th. They set a “buy” rating and a $5.00 price objective on the stock. Finally, DA Davidson boosted their price objective on shares of Waldencast from $6.50 to $7.25 and gave the stock a “buy” rating in a research note on Wednesday, September 4th.

About Waldencast

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.